SCHEMBL24959354

SCHEMBL24959354

CCc1cnc(C(N)=O)cc1OC

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SIRT6 Q8N6T7 1/20 0.49
▸ PDE4A P27815 2/20 0.44
▸ PDE4B Q07343 2/20 0.44
▸ PDE4C Q08493 2/20 0.44
▸ PDE4D Q08499 2/20 0.44
▸ MAPK1 P28482 1/20 0.43
▸ TAAR1 Q96RJ0 2/20 0.42
▸ ALDH1A1 P00352 2/20 0.41
▸ SMN1; SMN2 Q16637 1/20 0.41
▸ TSHR P16473 1/20 0.41
▸ NPSR1 Q6W5P4 1/20 0.41
▸ PDCD1 Q15116 3/20 0.41
▸ CD274 Q9NZQ7 3/20 0.41
▸ PDE10A Q9Y233 1/20 0.40
▸ DPP4 P27487 2/20 0.40
▸ NCOA1 Q15788 1/20 0.40
▸ NCOA3 Q9Y6Q9 1/20 0.40
▸ BPTF Q12830 1/20 0.40
▸ FGFR1 P11362 1/20 0.39
▸ FGFR4 P22455 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11858290 0.86 SIRT6 (0.43) SIRT6PDE4APDE4BPDE4CPDE4D
Hydrochloric Acid SCHEMBL11845874 0.85 SIRT6 (0.42) SIRT6PDE4APDE4BPDE4CPDE4D
SCHEMBL25730354 0.81 MEN1 (0.51) PDE4APDE4BPDE4CPDE4DALDH1A1
SCHEMBL30340441 0.80 PDCD1 (0.60) ALDH1A1TSHRNPSR1PDCD1CD274
SCHEMBL1673227 0.78 TSHR (0.50) SIRT6PDE4APDE4BPDE4CPDE4D
SCHEMBL15417758 0.77 NOS3 (0.56) SIRT6TSHRPDCD1CD274
SCHEMBL24960002 0.77 SIRT6 (0.49) SIRT6PDE4APDE4BPDE4CPDE4D
SCHEMBL4141457 0.76 DPP4 (0.42) PDE4APDE4BPDE4CPDE4DMAPK1
SCHEMBL24959359 0.76 SIRT6 (0.40) SIRT6TSHR
SCHEMBL24960105 0.75 SIRT6 (0.47) SIRT6PDE4APDE4BPDE4CPDE4D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230021705-A1 GLP-1R MODULATING COMPOUNDS GILEAD SCIENCES, INC. 2023-01-26 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230021705-A1 GLP-1R MODULATING COMPOUNDS GLP1R, GIPR, GPR119 SIRT6 764/4885PDE4A 71/4885PDE4B 112/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback